Epigenetic changes in osteosarcoma

被引：26

作者：

Cui, Juncheng ^{[1
]}

Wang, Wanchun ^{[1
]}

Li, Zhihong ^{[1
]}

Zhang, Zhaogui ^{[1
]}

Wu, Bei ^{[2
]}

Zeng, Li ^{[3
]}

机构：

[1] Cent S Univ, Xiangya Hosp 2, Dept Orthoped, Changsha, Hunan, Peoples R China

[2] Cent S Univ, Xiangya Hosp, Dept Orthoped, Changsha, Hunan, Peoples R China

[3] Nanhua Univ, Affiliated Hosp 1, Dept Med Cosmetol, Hengyang, Hunan, Peoples R China

来源：

BULLETIN DU CANCER | 2011年 / 98卷 / 07期

关键词：

osteosarcoma; epigenetics; DNA methylation; histone modifications; HISTONE DEACETYLASE INHIBITORS; SQUAMOUS-CELL CARCINOMA; DNA METHYLATION; GENE-EXPRESSION; CHONDROMODULIN-I; PROMOTER REGION; RECQL4; GENE; CPG ISLANDS; MYC GENE; CANCER;

D O I：

10.1684/bdc.2011.1400

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Osteosarcoma is one of the most prevalent primary bone tumors. The pathogenesis and molecular development of this tumor remains elusive. The prognosis is unfavorable due to lack of effective treatment methods. Recent advances in the epigenetics have brought a profound impact on the understanding of molecular mechanisms that lead to osteosarcoma. In this review, we summarized the current literature on epigenetic changes that are thought to contribute to the carcinogenesis of osteosarcoma, and discussed the potential diagnostic and therapeutic applications as well as future areas of research.

引用

页码：E62 / E68

页数：7

共 80 条

[1] ErbB2 expression is correlated with increased survival of patients with osteosarcoma
Akatsuka, T
Wada, T
Kokai, Y
Kawaguchi, S
Isu, K
Yamashiro, K
Yamashita, T
Sawada, N
Yamawaki, S
Ishii, S
[J]. CANCER, 2002, 94 (05) : 1397 - 1404
[2] HER2, TOP2A, CCND1, EGFR and c-MYC oncogene amplification in colorectal cancer
Al-Kuraya, Khawla
Novotny, Hedvika
Bavi, Prashant
Siraj, Abdul K.
Uddin, Shahab
Ezzat, Adnan
Al Sanea, Nasser
Al-Dayel, Fouad
Al-Mana, Hadeel
Sheikh, Salwa S.
Mirlacher, Martina
Tapia, Coya
Simon, Ronald
Sauter, Guido
Terracciano, Luigi
Tornillo, Luigi
[J]. JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (07) : 768 - 772
[3] Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation
Al-Romaih, Khaldoun
Somers, Gino R.
Bayani, Jane
Hughes, Simon
Prasad, Mona
Cutz, Jean-Claude
Xue, Hui
Zielenska, Maria
Wang, Yuzhuo
Squire, Jeremy A.
[J]. CANCER CELL INTERNATIONAL, 2007, 7 (1)
[4] Decitabine-induced demethylation of 5′ CpG island in GADD45A leads to apoptosis in osteosarcoma cells
Al-Romaih, Khaldoun
Sadikovic, Bekim
Yoshimoto, Maisa
Wang, Yuzhuo
Zielenska, Maria
Squire, Jeremy A.
[J]. NEOPLASIA, 2008, 10 (05): : 471 - 480
[5] CpG islands as genomic footprints of promoters that are associated with replication origins
Antequera, F
Bird, A
[J]. CURRENT BIOLOGY, 1999, 9 (17) : R661 - R667
[6] Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3
Aoyama, T
Okamoto, T
Nagayama, S
Nishijo, K
Ishibe, T
Yasura, K
Nakayama, T
Nakamura, T
Toguchida, J
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (27) : 28789 - 28797
[7] Cell-specific epigenetic regulation of ChM-I gene expression: Crosstalk between DNA methylation and histone acetylation
Aoyama, Tomoki
Okamoto, Takeshi
Kohno, Yoshiki
Fukiage, Kenichi
Otsuka, Seiji
Furu, Moritoshi
Ito, Kinya
Jin, Yonghui
Nagayama, Satoshi
Nakayama, Tomitaka
Nakamura, Takashi
Toguchida, Junya
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 365 (01) : 124 - 130
[8] Regulation of the p14ARF promoter by DNA methylation
Badal, Vinay
Menendez, Sergio
Coomber, David
Lane, David P.
[J]. CELL CYCLE, 2008, 7 (01) : 112 - 119
[9] DNA hypermethylation in tumorigenesis - epigenetics joins genetics
Baylin, SB
Herman, JG
[J]. TRENDS IN GENETICS, 2000, 16 (04) : 168 - 174
[10] Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
Baylin, SB
Ohm, JE
[J]. NATURE REVIEWS CANCER, 2006, 6 (02) : 107 - 116

← 1 2 3 4 5 6 7 8 →